What's the cheapest weight loss medication in 2026?
All 7 approved drugs compared by monthly cost — insurance, self-pay, savings programmes, and what to consider on a tight budget.
Read guide →Weight loss pills you don't have to inject
The 4 pill options compared — oral Wegovy, Foundayo, Qsymia, and Contrave. Weight loss, cost, convenience, and side effects.
Read guide →Mounjaro vs Ozempic — which one in 2026?
Head-to-head trial data, cost, side effects, and how to think about choosing between tirzepatide and semaglutide.
Read guide →I reached my goal weight — now what?
After stopping tirzepatide, SURMOUNT-4 found an average 14% body weight regain — only 16.6% kept 80% or more of their loss. What the regain data says.
Read guide →What actually happens when you stop taking Ozempic?
After stopping semaglutide, the STEP 1 follow-up found people regained about two-thirds of their lost weight within a year. What the trial data says.
Read guide →What should I eat on Ozempic, Zepbound, or the new pills?
Protein first and foods that fight nausea — plus the Wegovy pill's 30-minute rule and Foundayo's no-rules approach. No special diet required.
Read guide →Taking Zepbound, Wegovy or Saxenda before surgery: what to tell your anaesthetist
Why these drugs slow the stomach, what the 2023 and 2024 anaesthesia guidance says about holding them, and what your surgical team needs to know.
Read guide →Compounded semaglutide and tirzepatide vs the brand products
What compounding is, when it was legal during the shortages, what the FDA has recorded since, and the questions worth asking a pharmacy or clinic.
Read guide →Are Wegovy, Zepbound and Mounjaro still in shortage? What the FDA database says
How the FDA shortage database works, the dates each shortage was resolved, what that changed for compounding, and steps if your pharmacy is out.
Read guide →Savings programmes for Zepbound, Wegovy and Foundayo: what they actually cover
What the Zepbound, Wegovy and Foundayo savings pages actually state: copay caps, self-pay prices by dose, who is excluded, and the expiry dates.
Read guide →Wegovy, Zepbound, Saxenda, Qsymia and pregnancy or breastfeeding: what the labels say
What the FDA label for each of the seven approved weight loss drugs says about pregnancy, breastfeeding, contraception and Qsymia monthly testing.
Read guide →The thyroid cancer warning on Wegovy, Zepbound and Saxenda, explained
The boxed warning word for word, the rodent studies behind it, what the labels say is still unknown in humans, and which drugs carry no warning.
Read guide →Bariatric surgery or weight-loss medication: what the studies report
What the SOS study, the 2022 ASMBS/IFSO statement and the GLP-1 drug trials each report on weight loss, durability, risks, eligibility and cost.
Read guide →Next step most people take
Built with agentic AI tools and not a substitute for medical advice